MBD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.021600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.120600E-01
Normal-vs-Stage2
1.555940E-02
Normal-vs-Stage3
6.014200E-02
Normal-vs-Stage4
1.827360E-01
Stage1-vs-Stage2
4.690200E-01
Stage1-vs-Stage3
1.465180E-01
Stage1-vs-Stage4
5.507000E-01
Stage2-vs-Stage3
8.243700E-02
Stage2-vs-Stage4
7.096800E-01
Stage3-vs-Stage4
3.109400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.800400E-02
Normal-vs-AfricanAmerican
1.214760E-01
Normal-vs-Asian
2.306100E-02
Caucasian-vs-AfricanAmerican
9.800600E-01
Caucasian-vs-Asian
9.523600E-02
AfricanAmerican-vs-Asian
2.031200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.788310E-02
Normal-vs-Female
6.550500E-02
Male-vs-Female
2.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.514000E-01
Normal-vs-Age(41-60Yrs)
7.238200E-02
Normal-vs-Age(61-80Yrs)
2.546300E-02
Normal-vs-Age(81-100Yrs)
2.538000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.073200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.061200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.876200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.264500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.333600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.917400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.539200E-03
Normal-vs-Daily Drinker
5.504100E-02
Normal-vs-Weekly Drinker
2.070400E-01
Normal-vs-Occasional Drinker
8.446200E-02
Normal-vs-Social Drinker
2.075000E-01
Non Drinker-vs-Daily Drinker
3.967800E-01
Non Drinker-vs-Weekly Drinker
1.188020E-01
Non Drinker-vs-Occasional Drinker
2.263600E-02
Non Drinker-vs-Social Drinker
1.855810E-02
Daily Drinker-vs-Weekly Drinker
4.712000E-01
Daily Drinker-vs-Occasional Drinker
2.551600E-01
Daily Drinker-vs-Social Drinker
1.886420E-01
Weekly Drinker-vs-Occasional Drinker
8.610400E-01
Weekly Drinker-vs-Social Drinker
6.694600E-01
Occasional Drinker-vs-Social Drinker
7.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.793800E-01
Normal-vs-Grade 2
8.920200E-01
Normal-vs-Grade 3
9.025600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.654210E-01
Grade 1-vs-Grade 3
2.343600E-01
Grade 1-vs-Grade 4
9.793800E-01
Grade 2-vs-Grade 3
7.014000E-01
Grade 2-vs-Grade 4
8.920200E-01
Grade 3-vs-Grade 4
9.025600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.589000E-01
Normal-vs-NonDiabetic
6.009500E-02
Diabetic-vs-NonDiabetic
1.473180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.834600E-01
Normal-vs-NoPancreatitis
3.663500E-02
Pancreatitis-vs-NoPancreatitis
7.028000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.227800E-02
Normal-vs-N1
2.084400E-02
N0-vs-N1
7.194400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.037200E-01
Normal-vs-TP53-NonMutant
1.839970E-01
TP53-Mutant-vs-TP53-NonMutant
4.619000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
